| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/24/2008 | CA2666887A1 Alpha-msh therapies for treatment of autoimmune disease |
| 04/24/2008 | CA2666840A1 Inhibition of degradation of extracellular matrix |
| 04/24/2008 | CA2666458A1 Antibody molecules which bind il-17a and il-17f |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1914243A2 Anti-CD40 monoclonal antibody |
| 04/23/2008 | EP1914223A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 04/23/2008 | EP1913957A1 Adjuvanted genetic vaccines |
| 04/23/2008 | EP1913954A2 Agents and methods based on the use of the eda domain of fibronectin |
| 04/23/2008 | EP1912941A1 Novel piperidine derivatives |
| 04/23/2008 | EP1912675A2 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 04/23/2008 | EP1605039B1 Dendritic cell presenting alpha-glycosylceramide derivative and a ntigen and usable in suppressing immune response |
| 04/23/2008 | EP1434858B1 Method for the amplification of a poxvirus under serum free conditions |
| 04/23/2008 | EP1251871B1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and as adjuvants an immunogenic oligodeoxynucleotide and a polycationic polypeptide |
| 04/23/2008 | EP1219612B1 2-imino-1,3-thiazine derivatives |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | EP0804212B1 Nigella sativa as a medicinal treatment |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166760A A molecule and chimeric molecules thereof |
| 04/23/2008 | CN101166721A 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 04/23/2008 | CN101166559A Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 04/23/2008 | CN101166542A KIM-1 antibodies for treatment of TH2-mediated conditions |
| 04/23/2008 | CN101166510A External preparation for skin |
| 04/23/2008 | CN101165070A A series of fusion protein with dual biological activity and medical treatment thereof |
| 04/23/2008 | CN101165047A Glycolipid derivative and its manufacturing method, and its synthesizing intermediate and its manufacturing method |
| 04/23/2008 | CN101164616A Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 04/23/2008 | CN101164615A BAFF, inhibitors thereof and their use in the modulation of B-cell response |
| 04/23/2008 | CN101164614A Use of phytohemagglutinin for promoting animal immunity |
| 04/23/2008 | CN101164603A Compound concentrating matrimony vine capsule and preparation method thereof |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN101164542A Use of mometasone furoate for preparing drug |
| 04/23/2008 | CN101164539A New use of staurosporine derivatives |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100382844C Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies |
| 04/23/2008 | CN100382831C Eczema treating Chinese medicine preparation |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361687 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/22/2008 | US7361660 Chemical compounds |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361348 Immunogenic glycopeptides, screening, preparation and uses |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2239582C A new therapeutic use for glycine |
| 04/22/2008 | CA2129542C Pharmaceutical preparation based on rhamnolipid |
| 04/17/2008 | WO2008045543A1 Substituted 4h-imidazo [4, 5, 1-ij] [1, 6] naphthyridine-9-amines and their pharmaceutical use |
| 04/17/2008 | WO2008045358A1 Porphyrin catalysts and methods of use thereof |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044465A1 Method of utilizing thrombin as adjuvant |
| 04/17/2008 | WO2008044076A2 Therapy targeting cathepsin s |
| 04/17/2008 | WO2008043782A2 Modulation of cd1b or cd1d expression in autoimmune disorders |
| 04/17/2008 | WO2008043570A1 Interferon type i supporting compounds |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |
| 04/17/2008 | WO2008043157A1 Compositions and methods for modulating immune responses |
| 04/17/2008 | WO2008025507A3 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 04/17/2008 | WO2008016665A3 Imidazoacridine compounds for treating flt3 -mediated disorders |
| 04/17/2008 | WO2008012031A3 Blockers of gsk3 for the prevention and treatment of pemphigus vulgaris |
| 04/17/2008 | WO2008003748A3 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 04/17/2008 | WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors |
| 04/17/2008 | WO2007143745A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/17/2008 | WO2007141667A3 Immunosuppressive extract of cordyceps sinensis and uses thereof |
| 04/17/2008 | WO2006125963A3 Modified leukocyte ig-like receptor family members (lir' s) with increased affinity for class i mhc and their uses in modulating t cell activation |
| 04/17/2008 | US20080091263 Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090913 Sphingolipid-Derived Phamaceutical Compositions |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090844 Infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus; Immunomodulators; antiviral and antitumor agents; modulation of cytokine receptors; improved oral tolerability |
| 04/17/2008 | US20080090823 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 04/17/2008 | US20080090819 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE |
| 04/17/2008 | US20080090813 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090792 Selective glucocorticoid receptor agonists |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090779 2-Benzyloxy-5-(2-bromoacetyl)-N-[3,5-bis(trifluoromethyl)phenyl-benzamide; diseases caused by production of immunoglobulin E: inflammatory cytokine, histamine, leukotriene and degranulation from activated mast cell; pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis, hysteromyoma |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090752 Anti-tumor vasculature effects of human serum albumin derivatives |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089950 Lymphoid tissue inducers and an immunomodulatory agent; proliferative disorders, infectious diseases, cardiovascular diseases, inflammatory disorders and autoimmune disorders |
| 04/17/2008 | US20080089939 Dermastick thickened ointment |
| 04/17/2008 | US20080089929 Immunogenic fusion comprising transcription and negative factor domains for use in generation vaccine for prevention and treatment of viral infections; immunostimulants |
| 04/17/2008 | US20080089911 Borrelia burgdorferi outer surface protein ( OSP)C antigen and a second antigenic lipoprotein such as genetic engineered OSPA, or streptococcus pneumoniae cell surface protein ( PSPA) or both in same physio-chemical |
| 04/17/2008 | US20080089907 Modified vaccinia Ankara virus variant |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | US20080089894 Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089885 Anti-cd20 antibodies and methods of use |
| 04/17/2008 | US20080089859 Administration of sleep restorative agents |
| 04/17/2008 | US20080089838 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer |
| 04/17/2008 | DE102006050026A1 Use of lactic acid compounds as tumor necrosis factor-alpha blocker, e.g. for suppressing immune system, for prophylaxis and/or treatment of autoimmune diseases and/or inflammatory diseases, preferably rheumatoid arthritis, spondylitis |
| 04/17/2008 | CA2702340A1 Compositions and methods for modulating immune responses |
| 04/16/2008 | EP1911761A1 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911458A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |